psalexa
logo

Protein Expression Market

Protein Expression Market by System (Prokaryotic Expression Systems, Mammalian Cell Expression Systems, Insect Cell Expression Systems, Yeast Expression Systems, Cell-Free Expression Systems, Algal-Based Expression Systems), by Product & Services (Reagents, Expression Vectors, Competent Cells, Services, Instruments), by Application (Therapeutic, Industrial, Research), by End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations), by Geography (US, Canada, UK, Germany, France, Italy, Spain, China, India, Japan, Brazil, Mexico, South Africa) - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

Published: October 2017
Report Code: LS11116
Available Format:
Pages: 231
Category : Biotechnology

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by System

1.3.2 Market Segmentation by Product & Services

1.3.3 Market Segmentation by Application

1.3.4 Market Segmentation by End User

1.3.5 Market Segmentation by Geography

1.3.6 Analysis Period

1.3.7 Market Data Reporting Unit

1.3.7.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Data Triangulation

2.4 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By System

4.1.1.1 Prokaryotic expression systems

4.1.1.1.1 Escherichia coli systems

4.1.1.1.2 Other prokaryotic expression system

4.1.1.2 Mammalian cell expression systems

4.1.1.2.1 Chinese hamster ovary(CHO) systems

4.1.1.2.2 Other mammalian cell systems

4.1.1.3 Insect cell expression systems

4.1.1.3.1 Baculovirus systems

4.1.1.3.2 Other insect cell systems

4.1.1.4 Yeast expression systems

4.1.1.4.1 K. Lactis systems

4.1.1.4.2 Saccharomyces systems

4.1.1.4.3 Pichia systems

4.1.1.4.4 Other yeast expression systems

4.1.1.5 Cell-free expression systems

4.1.1.6 Algal-based expression systems

4.1.2 By Products & Services

4.1.2.1 Reagents

4.1.2.2 Expression vectors

4.1.2.3 Competent cells

4.1.2.4 Instruments

4.1.2.5 Services

4.1.3 By Application

4.1.3.1 Therapeutic

4.1.3.2 Industrial

4.1.3.3 Research

4.1.4 By End User

4.1.4.1 Pharmaceutical and biotechnology companies

4.1.4.2 Academic research institutes

4.1.4.3 Contract research organizations

4.1.4.4 Others

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Increasing number of acquisitions

4.2.1.2 Increasing research activities on recombinant-based protein expression

4.2.2 Drivers

4.2.2.1 Increasing prevalence of chronic diseases

4.2.2.2 Aging population

4.2.2.3 Increasing growth in life science sector

4.2.2.4 Availability of funding for protein-based research

4.2.2.5 Technological advancements

4.2.2.6 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 Increasing market consolidation affecting new entrants

4.2.3.2 High cost of protein expression reagents and instruments

4.2.3.3 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Untapped market in various emerging economies

4.2.4.2 Emergence of microfluidics

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining power of buyers

4.3.2 Bargaining power of suppliers

4.3.3 Threat of new entrants

4.3.4 Intensity of rivalry

4.3.5 Threat of substitutes

Chapter 5. Global Market Size and Forecast

5.1 Global Protein Expression Market, by System

5.1.1 Global Prokaryotic Expression Systems Market, by Type

5.1.2 Global Mammalian Cell Expression Systems Market, by Type

5.1.3 Global Insect Cell Expression Systems Market, by Type

5.1.4 Global Yeast Expression Systems Market, By Type

5.2 Global Protein Expression Market, by Product & Services

5.3 Global Protein Expression Market, by Application

5.4 Global Protein Expression Market, by End User

5.5 Global Protein Expression Market, by Region

Chapter 6. North America Market Size and Forecast

6.1 North America Protein Expression Market, by System

6.1.1 North America Prokaryotic Expression System Market, by Type

6.1.2 North America Mammalian Cell Expression Systems Market, by Type

6.1.3 North America Insect Cell Expression Systems Market, by Type

6.1.4 North America Yeast Expression Systems Market, by Type

6.2 North America Protein Expression Market, by Product & Services

6.3 North America Protein Expression Market, by Application

6.4 North America Protein Expression Market, by End User

6.5 North America Protein Expression Market, by Country

Chapter 7. Europe Market Size and Forecast

7.1 Europe Protein Expression Market, by System

7.1.1 Europe Prokaryotic Expression System Market, by Type

7.1.2 Europe Mammalian Cell Expression Systems Market, by Type

7.1.3 Europe Insect Cell Expression Systems Market, by Type

7.1.4 Europe Yeast Expression Systems Market, by Type

7.2 Europe Protein Expression Market, by Product & Services

7.3 Europe Protein Expression Market, by Application

7.4 Europe Protein Expression Market, by End User

7.5 Europe Protein Expression Market, by Country

Chapter 8. Asia- Pacific Market Size and Forecast

8.1 Asia-Pacific Protein Expression Market, by System

8.1.1 Asia-Pacific Prokaryotic Expression System Market, by Type

8.1.2 Asia-Pacific Mammalian Cell Expression Systems Market, by Type

8.1.3 Asia-Pacific Insect Cell Expression Systems Market, by Type

8.1.4 Asia-Pacific Yeast Expression Systems Market, by Type

8.2 Asia-Pacific Protein Expression Market, by Product & Services

8.3 Asia-Pacific Protein Expression Market, by Application

8.4 Asia-Pacific Protein Expression Market, by End User

8.5 Asia-Pacific Protein Expression Market, by Country

Chapter 9. Latin America Market Size and Forecast

9.1 Latin America Protein Expression Market, by System

9.1.1 Latin America Prokaryotic Expression System Market, by Type

9.1.2 Latin America Mammalian Cell Expression Systems Market, by Type

9.1.3 Latin America Insect Cell Expression Systems Market, by Type

9.1.4 Latin America Yeast Expression Systems Market, by Type

9.2 Latin America Protein Expression Market by Product & Services

9.3 Latin America Protein Expression Market, by Application

9.4 Latin America Protein Expression Market, by End User

9.5 Latin America Protein Expression Market, by Country

Chapter 10. Middle East and Africa Market Size and Forecast

10.1 MEA Protein Expression Market, by System

10.1.1 Mea Prokaryotic Expression System Market, by Type

10.1.2 Mea Mammalian Cell Expression Systems Market, by Type

10.1.3 Mea Insect Cell Expression Systems Market, by Type

10.1.4 Mea Yeast Expression Systems Market, by Type

10.2 MEA Protein Expression Market, by Product & Services

10.3 MEA Protein Expression Market, by Application

10.4 MEA Protein Expression Market, by End User

10.5 MEA Protein Expression Market, by Country

Chapter 11. Global Mammalian Cell Expression System Market

11.1 Market Size for Recombinant Protein Production

11.1.1 Global Mammalian Cell Expression Systems Market for Recombinant Protein Production, by Application

11.1.2 North America Mammalian Cell Expression Systems Market for Recombinant Protein Production, By Application

11.1.3 Europe Mammalian Cell Expression Systems Market for Recombinant Protein Production, by Application

11.1.4 Asia-Pacific Mammalian Cell Expression Systems Market for Recombinant Protein Production, by Application

11.1.5 Latin America Mammalian Cell Expression Systems Market for Recombinant Protein Production, by Application

11.1.6 MEA Mammalian Cell Expression Systems Market for Recombinant Protein Production, by Application

11.2 Market Size for Recombinant Antibody Production

11.2.1 Global Mammalian Cell Expression Systems Market for Recombinant Antibody Production, by Application

11.2.2 North America Mammalian Cell Expression Systems Market for Recombinant Antibody Production, by Application

11.2.3 Europe Mammalian Cell Expression Systems Market for Recombinant Antibody Production, by Application

11.2.4 Asia-Pacific Mammalian Cell Expression Systems Market for Recombinant Antibody Production, by Application

11.2.5 Latin America Mammalian Cell Expression Systems Market for Recombinant Antibody Production, by Application

11.2.6 MEA Mammalian Cell Expression Systems Market for Recombinant Antibody Production, by Application

11.3 Market Share Analysis for Recombinant Antibody Production

11.4 Recombinant Antibody Production – Key Players

11.4.1 Abnova Corporation

11.4.2 General Electric Company

11.4.3 Sino Biological Inc.

11.4.4 Bioventix plc

Chapter 12. Competitive Landscape

12.1 Market Share Analysis of Key Players

12.2 Competitive Analysis of Key Players

12.3 Product Benchmarking of Key Players

12.4 Global Strategic Developments of Key Players

12.4.1 Merger and Acquisition

12.4.2 Product Launch/Approvals

12.4.3 Partnership

12.4.4 Other Developments

Chapter 13. Company Profiles

13.1 Thermo Fisher Scientific Inc.

13.1.1 Business Overview

13.1.2 Product and Service Offerings

13.1.3 Key Financial Summary

13.1.4 Strategic Growth Plans

13.2 Merck KGaA

13.2.1 Business Overview

13.2.2 Product and Service Offerings

13.2.3 Key Financial Summary

13.2.4 Strategic Growth Plans

13.3 Genscript Biotech Corporation

13.3.1 Business Overview

13.3.2 Product and Service Offerings

13.3.3 Key Financial Summary

13.3.4 Strategic Growth Plans

13.4 Agilent Technologies, Inc.

13.4.1 Business Overview

13.4.2 Product and Service Offerings

13.4.3 Key Financial Summary

13.4.4 Strategic Growth Plans

13.5 Takara Holdings Inc.

13.5.1 Business Overview

13.5.2 Product and Service Offerings

13.5.3 Key Financial Summary

13.5.4 Strategic Growth Plans

13.6 Promega Corporation

13.6.1 Business Overview

13.6.2 Product and Service Offerings

13.6.3 Strategic Growth Plans

13.7 Bio-Rad Laboratories, Inc.

13.7.1 Business Overview

13.7.2 Product and Service Offerings

13.7.3 Key Financial Summary

13.7.4 Strategic Growth Plans

13.8 Qiagen N.V.

13.8.1 Business Overview

13.8.2 Product and Service Offerings

13.8.3 Key Financial Summary

13.8.4 Strategic Growth Plans

13.9 Lonza Group Ltd.

13.9.1 Business Overview

13.9.2 Product and Service Offerings

13.9.3 Key Financial Summary

13.9.4 Strategic Growth Plans

13.1 New England Biolabs Inc.

13.10.1 Business Overview

13.10.2 Product and Service Offerings

13.10.3 Strategic Growth Plans

Chapter 14. Appendix

14.1 Abbreviations

14.2 Related Reports

LIST OF TABLES

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 HEALTHCARE EXPENDITURE AS % OF GDP

TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 PRICE OF VARIOUS PRODUCTS OFFERED BY KEY PLAYERS

TABLE 5 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 6 GLOBAL PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2016)

TABLE 7 GLOBAL PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2017 – 2023)

TABLE 8 GLOBAL PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 9 GLOBAL PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 10 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 11 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 12 GLOBAL INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 13 GLOBAL INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 14 GLOBAL YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 15 GLOBAL YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 16 GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2016)

TABLE 17 GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2017 – 2023)

TABLE 18 GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 19 GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 20 GLOBAL PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2016)

TABLE 21 GLOBAL PROTEIN EXPRESSION MARKET, BY END USER, $M (2017 – 2023)

TABLE 22 GLOBAL PROTEIN EXPRESSION MARKET, BY REGION, $M (2013 – 2016)

TABLE 23 GLOBAL PROTEIN EXPRESSION MARKET, BY REGION, $M (2017 – 2023)

TABLE 24 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2016)

TABLE 25 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2017 – 2023)

TABLE 26 NORTH AMERICA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2016)

TABLE 27 NORTH AMERICA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2017 – 2023)

TABLE 28 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 29 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 30 NORTH AMERICA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 31 NORTH AMERICA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 32 NORTH AMERICA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 33 NORTH AMERICA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 34 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2016)

TABLE 35 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2017 – 2023)

TABLE 36 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 37 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 38 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2016)

TABLE 39 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY END USER, $M (2017 – 2023)

TABLE 40 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 41 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 42 EUROPE PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2016)

TABLE 43 EUROPE PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, $M (2017 – 2023)

TABLE 44 EUROPE PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2016)

TABLE 45 EUROPE PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2017 – 2023)

TABLE 46 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 47 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 48 EUROPE INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 49 EUROPE INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 50 EUROPE YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 51 EUROPE YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 52 EUROPE PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2016)

TABLE 53 EUROPE PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2017 – 2023)

TABLE 54 EUROPE PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 55 EUROPE PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 56 EUROPE PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2016)

TABLE 57 EUROPE PROTEIN EXPRESSION MARKET, BY END USER, $M (2017 – 2023)

TABLE 58 EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 59 EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 60 TOP ASIA-PACIFIC COUNTRIES IN R&D SPENDING

TABLE 61 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2016)

TABLE 62 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2017 – 2023)

TABLE 63 ASIA-PACIFIC PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2016)

TABLE 64 ASIA-PACIFIC PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2017 – 2023)

TABLE 65 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 66 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 67 ASIA-PACIFIC INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 68 ASIA-PACIFIC INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 69 ASIA-PACIFIC YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 70 ASIA-PACIFIC YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 71 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2016)

TABLE 72 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2017 – 2023)

TABLE 73 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 74 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 75 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2016)

TABLE 76 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY END USER, $M (2017 – 2023)

TABLE 77 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 78 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 79 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2016)

TABLE 80 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2017 – 2023)

TABLE 81 LATIN AMERICA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2016)

TABLE 82 LATIN AMERICA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2017 – 2023)

TABLE 83 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 84 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 85 LATIN AMERICA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 86 LATIN AMERICA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 87 LATIN AMERICA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 88 LATIN AMERICA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 89 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2016)

TABLE 90 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2017 – 2023)

TABLE 91 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 92 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 93 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2016)

TABLE 94 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY END USER, $M (2017 – 2023)

TABLE 95 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 96 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 97 MEA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2016)

TABLE 98 MEA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2017 – 2023)

TABLE 99 MEA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2016)

TABLE 100 MEA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2017 – 2023)

TABLE 101 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 102 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 103 MEA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 104 MEA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 105 MEA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 106 MEA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 107 MEA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2016)

TABLE 108 MEA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2017 – 2023)

TABLE 109 MEA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 110 MEA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 111 MEA PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2016)

TABLE 112 MEA PROTEIN EXPRESSION MARKET, BY END USER, $M (2017 – 2023)

TABLE 113 MEA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 114 MEA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 115 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 116 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 117 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 118 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 119 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 120 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 121 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 122 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 123 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 124 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 125 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 126 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 127 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 128 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 129 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 130 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 131 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 132 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 133 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 134 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 135 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 136 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 137 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 138 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 139 ABNOVA CORPORATION – AT A GLANCE

TABLE 140 GENERAL ELECTRIC COMPANY– AT A GLANCE

TABLE 141 SINO BIOLOGICAL INC. – AT A GLANCE

TABLE 142 BIOVENTIX PLC – AT A GLANCE

TABLE 143 COMPETITIVE ANALYSIS OF KEY PLAYERS

TABLE 144 THERMO FISHER SCIENTIFIC INC. – AT A GLANCE

TABLE 145 THERMOFISHER SCIENTIFIC INC. – KEY FINANCIAL SUMMARY

TABLE 146 MERCK KGAA – AT A GLANCE

TABLE 147 MERCK KGAA – KEY FINANCIAL SUMMARY

TABLE 148 GENSCRIPT BIOTECH CORPORATION – AT A GLANCE

TABLE 149 GENSCRIPT BIOTECH CORPORATION – KEY FINANCIAL SUMMARY

TABLE 150 AGILENT TECHNOLOGIES, INC. – AT A GLANCE

TABLE 151 AGILENT TECHNOLOGIES, INC. – KEY FINANCIAL SUMMARY

TABLE 152 TAKARA HOLDINGS INC. – AT A GLANCE

TABLE 153 TAKARA HOLDINGS INC. – KEY FINANCIAL SUMMARY

TABLE 154 PROMEGA CORPORATION – AT A GLANCE

TABLE 155 BIO-RAD LABORATORIES, INC. – AT A GLANCE

TABLE 156 BIO-RAD LABORATORIES, INC. – KEY FINANCIAL SUMMARY

TABLE 157 QIAGEN N.V. – AT A GLANCE

TABLE 158 QIAGEN N.V. – KEY FINANCIAL SUMMARY

TABLE 159 LONZA GROUP LTD. – AT A GLANCE

TABLE 160 LONZA GROUP LTD. – KEY FINANCIAL SUMMARY

TABLE 161 NEW ENGLAND BIOLABS INC. – AT A GLANCE

LIST OF FIGURES

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL PROTEIN EXPRESSION MARKET SUMMARY

FIG 9 AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION

FIG 10 PORTER’S FIVE FORCES ANALYSIS

FIG 11 SNAPSHOT OF PROTEIN EXPRESSION MARKET BY SYSTEM (2016)

FIG 12 GLOBAL PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2023)

FIG 13 GLOBAL PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 14 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 15 GLOBAL INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 16 GLOBAL YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 17 GLOBAL PROTEIN EXPRESSION MARKET SPLIT, BY PRODUCT & SERVICES (2016)

FIG 18 GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2023)

FIG 19 GLOBAL PROTEIN EXPRESSION MARKET SPLIT, BY APPLICATION (2016)

FIG 20 GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 21 GLOBAL PROTEIN EXPRESSION MARKET SPLIT, BY END-USER (2016)

FIG 22 GLOBAL PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2023)

FIG 23 WORLDWIDE MAJOR MARKETS FOR PROTEIN EXPRESSION

FIG 24 NORTH AMERICA PROTEIN EXPRESSION MARKET SNAPSHOT

FIG 25 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2023)

FIG 26 NORTH AMERICA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2023)

FIG 27 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 28 NORTH AMERICA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 29 NORTH AMERICA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 30 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2023)

FIG 31 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 32 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2023)

FIG 33 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 34 EUROPE PROTEIN EXPRESSION MARKET SNAPSHOT

FIG 35 EUROPE PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2023)

FIG 36 EUROPE PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2023)

FIG 37 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 38 EUROPE INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 39 EUROPE YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 40 EUROPE PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2023)

FIG 41 EUROPE PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 42 EUROPE PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2023)

FIG 43 EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 44 ASIA- PACIFIC PROTEIN EXPRESSION MARKET SNAPSHOT

FIG 45 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2023)

FIG 46 ASIA-PACIFIC PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2023)

FIG 47 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 48 ASIA-PACIFIC INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 49 ASIA-PACIFIC YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 50 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2023)

FIG 51 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 52 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2023)

FIG 53 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 54 LATIN AMERICA PROTEIN EXPRESSION MARKET SNAPSHOT

FIG 55 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2023)

FIG 56 LATIN AMERICA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2023)

FIG 57 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 58 LATIN AMERICA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 59 LATIN AMERICA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 60 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2023)

FIG 61 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 62 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2023)

FIG 63 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 64 MEA PROTEIN EXPRESSION MARKET SNAPSHOT

FIG 65 MEA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2023)

FIG 66 MEA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2023)

FIG 67 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 68 MEA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 69 MEA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 70 MEA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2023)

FIG 71 MEA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 72 MEA PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2023)

FIG 73 MEA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 74 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 75 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 76 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 77 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 78 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 79 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 80 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 81 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 82 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 83 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 84 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 85 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 86 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON - MARKET SHARE OF KEY PLAYERS (2016)

FIG 87 GLOBAL PROTEIN EXPRESSION MARKET SHARE OF KEY PLAYERS (2016)

FIG 88 PRODUCT BENCHMARKING OF KEY PLAYERS

FIG 89 REVENUE SPLIT BY SEGMENT (2016)

FIG 90 THERMOFISHER SCIENTIFIC INC. - REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 91 MERCK KGAA - REVENUE SPLIT BY SEGMENT (2016)

FIG 92 MERCK KGAA - REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 93 GENSCRIPT BIOTECH CORPORATION - REVENUE SPLIT BY SEGMENT (2016)

FIG 94 GENSCRIPT BIOTECH CORPORATION - REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 95 AGILENT TECHNOLOGIES, INC. - REVENUE SPLIT BY SEGMENT (2016)

FIG 96 AGILENT TECHNOLOGIES, INC. - REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 97 TAKARA HOLDINGS INC. - REVENUE SPLIT BY SEGMENT (2017)

FIG 98 TAKARA HOLDINGS INC. - REVENUE SPLIT BY GEOGRAPHY (2017)

FIG 99 BIO-RAD LABORATORIES, INC. - REVENUE SPLIT BY SEGMENT (2016)

FIG 100 BIO-RAD LABORATORIES, INC. - REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 101 QIAGEN N.V. - REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 102 LONZA GROUP LTD. - REVENUE SPLIT BY SEGMENT (2016)

FIG 103 LONZA GROUP LTD. - REVENUE SPLIT BY GEOGRAPHY (2016) 

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5500
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry